JAMP INDAPAMIDE DIN 02567849
Health Canada record
| Active ingredient(s) | INDAPAMIDE 1.25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C03BA11 INDAPAMIDE |
| Original market date | |
| Current status date | 23-Apr-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INDAPAMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02245246 | APO-INDAPAMIDE 1.25 MG TABLETS | APOTEX INC | Tablet | INDAPAMIDE 1.25 MG | Marketed |
| 02223678 | APO-INDAPAMIDE 2.5MG TABLETS | APOTEX INC | Tablet | INDAPAMIDE 2.5 MG | Marketed |
| 02567857 | JAMP INDAPAMIDE | JAMP PHARMA CORPORATION | Tablet | INDAPAMIDE 2.5 MG | Approved |
| 02240067 | MYLAN-INDAPAMIDE | MYLAN PHARMACEUTICALS ULC | Tablet | INDAPAMIDE 1.25 MG | Marketed |
| 02153483 | MYLAN-INDAPAMIDE | MYLAN PHARMACEUTICALS ULC | Tablet | INDAPAMIDE 2.5 MG | Marketed |
| 02239913 | DOM-INDAPAMIDE TABLETS 1.25MG | DOMINION PHARMACAL | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02239917 | DOM-INDAPAMIDE TABLETS 2.5MG | DOMINION PHARMACAL | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02365324 | INDAPAMIDE | SANIS HEALTH INC | Tablet | INDAPAMIDE 2.5 MG | Cancelled Pre Market |
| 02445832 | INDAPAMIDE | SANIS HEALTH INC | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02445824 | INDAPAMIDE | SANIS HEALTH INC | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02227339 | INDAPAMIDE HEMIHYDRATE 1.25MG - TAB | PROVAL PHARMA DIVISION OF SERVIER CANADA INC | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02049341 | INDAPAMIDE HEMIHYDRATE TAB 2.5MG | PROVAL PHARMA DIVISION OF SERVIER CANADA INC | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02229762 | INDAPAMIDE-2.5 | PRO DOC LIMITEE | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02373912 | JAMP-INDAPAMIDE | JAMP PHARMA CORPORATION | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02373904 | JAMP-INDAPAMIDE | JAMP PHARMA CORPORATION | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 00564966 | LOZIDE | SERVIER CANADA INC | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02179709 | LOZIDE | SERVIER CANADA INC | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02362015 | NTP-INDAPAMIDE | TEVA CANADA LIMITED | Tablet | INDAPAMIDE 2.5 MG | Cancelled Pre Market |
| 02337118 | NU-INDAPAMIDE | NU-PHARM INC | Tablet | INDAPAMIDE 1.25 MG | Cancelled (Unreturned Annual) |
| 02223597 | NU-INDAPAMIDE - TAB 2.5MG | NU-PHARM INC | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02240350 | PHL-INDAPAMIDE | PHARMEL INC | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02240349 | PHL-INDAPAMIDE | PHARMEL INC | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02239620 | PMS-INDAPAMIDE | PHARMASCIENCE INC | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02239619 | PMS-INDAPAMIDE | PHARMASCIENCE INC | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02312530 | PRO-INDAPAMIDE | PRO DOC LIMITEE | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02312549 | PRO-INDAPAMIDE | PRO DOC LIMITEE | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02247245 | RIVA-INDAPAMIDE 1.25 | LABORATOIRE RIVA INC. | Tablet | INDAPAMIDE 1.25 MG | Cancelled Post Market |
| 02242125 | RIVA-INDAPAMIDE 2.5 MG | LABORATOIRE RIVA INC. | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
| 02231184 | TEVA-INDAPAMIDE | TEVA CANADA LIMITED | Tablet | INDAPAMIDE 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37392 | 2026-04-23 | Abbreviated New Drug Submission (ANDS) |
International API supply for INDAPAMIDE
8 valid EDQM Certificates of Suitability from 8 holders. 4 active FDA Drug Master Files.
Request a quote for JAMP INDAPAMIDE